Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 6 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 11813316

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  2. US 11814440

    Glypican 2 as a cancer marker and therapeutic target

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  3. US 11806369

    Exosomes and miRNA to treat glaucoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  4. US 11806406

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  5. US 11795235

    Immunotoxins with albumin binding domain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  6. US 11793871

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  7. US 11786589

    Human rotavirus strains and vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  8. US 11786591

    Recombinant metapneumovirus F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  9. US 11787764

    Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  10. US 11779601

    Diagnostic methods for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  11. US 11779603

    HERV-E reactive T cell receptors and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  12. US 11779570

    Method for inhibiting dengue virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  13. US 11782065

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  14. US 11781955

    Photo-controlled removal of targets in vitro and in vivo

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  15. US 11780885

    Zika viral antigen constructs

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  16. US 11780931

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  17. US 11771737

    Treating or preventing adverse liver conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  18. US 11759513

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  19. US 11760794

    Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  20. US 11760790

    Neutralizing antibodies to HIV-1 Env and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  21. US 11753627

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  22. US 11753408

    Compounds and method for blocking transmission of malarial parasite

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  23. US 11752138

    Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  24. US 11739063

    DREADD actuators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.